Abstract Index

Arthritis & Rheumatism, Volume 62,
November 2010 Abstract Supplement

Abstracts of the American College of
Rheumatology/Association of Rheumatology Health Professionals
Annual Scientific Meeting
Atlanta, Georgia November 6-11, 2010.

A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U | V | W | X | Y | Z


B Cell-Dependent Regulation (Breg) of T-Cell Proliferation Is Deficient in Systemic Lupus Erythematosus (SLE).
Pers Jacques-Olivier, Lemoine Sébastien, Morva Ahsen, Jamin Christophe, Youinou Pierre

B Cells Induced Proteinuria and Glomerulopathy in Absence of Immune Complexes Similar to Minimal Change Disease.
Kim Alfred H., Shaw Andrey S.

B Cells Modify Regulatory T Cells in Healthy Individuals but Not in Patients with Systemic Lupus Erythematosus.
N. Lazarus Mark, S. Kalsi Hardeep, A. Isenberg David, R. Ehrenstein Michael

Bach1 Regulates Heme Oxygenase-1 Expression of Human Monocytes in Response to LPS: Implication in Behcet's Disease.
Takeno Mitsuhiro, Miyazaki Takuya, Kirino Yohei, Samukawa Sei, Hama Maasa, Ishigatsubo Yoshiaki

BAFF Binding Receptors (BBR) Related To Relapse after Rituximab in Patients with Reumatoid Arthritis (RA).
Torre Inmaculada De la, Valor Lara, Moura Rita, Leandro Maria J., Edwards Jonathan C. W., Cambridge Geraldine

BAFF Expression Correlates with Idiopathic Inflammatory Myopathy Disease Activity Measures, Interferon Signature and Autoantibodies.
McNallan Kelly T., Bilgic Hatice, Crowson Cynthia S., Ytterberg Steven R., Amin Shreyasee, Erik Peterson J., Baechler Emily C., Reed Ann M.

BAFF Expression on the Surface of RA Synovial Fibroblasts (RASFib) Facilitates B Cell Responses to IL-15.
Garcia-Carmona Yolanda, Benito-Miguel Marta, Balsa Alejandro, Martin-Mola Emilio, Eugenia Miranda-Carus Maria

Baseline ADAMTS5 Expression Could Sort the Prediction of Response to Infliximab or Adalimumab in Patients with Rheumatoid Arthritis.
Tsuzaka Kensei, Itami Yuka, Shinozaki Naoshi, Morishita Tetsuo

Baseline Characteristics of Patients with Non-Infectious Mixed Cryoglobulinemia Vasculitis: Results from the French Nationwide CryoVas Survey.
Terrier Benjamin, Marie Isabelle, Lacraz Adeline, Launay David, Plaisier Emmanuelle, Kahn Jean-Emmanuel, de Saint-Martin Luc, Bonnet Fabrice, Le Guenno Guillaume, Diot Elisabeth, Rullier Patricia, Seror Raphaële, Lazaro Estabaliz, Hermine Olivier, Leger Jean-Marc, Senet Patricia, Mariette Xavier, Cacoub Patrice

Baseline Characteristics of Patients with Type I Monoclonal Cryoglobulinemia Vasculitis: Results from the French Nationwide CryoVas Survey.
Terrier Benjamin, Marie Isabelle, Kahn Jean-Emmanuel, Le Guenno Guillaume, Karras Alexandre, Lacraz Adeline, Hermine Olivier, de Saint-Martin Luc, Diot Elisabeth, Modiano Philippe, Leblond Véronique, Senet Patricia, Leger Jean-Marc, Plaisier Emmanuelle, Mariette Xavier, Saadoun David, Cacoub Patrice

Baseline CRP Predicts Early Improvement in Synovitis, Osteitis, and Erosion on MRI in RA Patients Treated with Tocilizumab: Results from the ACT-RAY MRI Substudy.
Troum Orrin M., Peterfy Charles G., Kaine Jeffrey L., Chung Carol, Anisfeld Andrew, Olech Ewa, Conaghan Philip G.

Baseline Differences in the Borderline Pulmonary Hypertension vs. Normal Hemodynamics: PHAROS Registry.
Khanna Dinesh, Saggar Rajeev, Furst Daniel, Chung Lorinda, Seibold James, Frech Tracy, Schiopu ELENA, Saggar Rajan, Bolster Marcy, Steen Virginia, PHAROS Investigators 

Baseline Factors Related to Response to Conventional DMARD Treatments.
Sterling Kimberly L., Carter Gebra Cuyun, Messing Susan, Reed George, Chen Rui, Kaukeinen Kimberly, Tu Xin, Nelson David R., Sarsour Khaled, Cantrell Ronald A., Alatorre Carlos I., Greenberg Jeffrey

Baseline Serum Interleukin-6 (IL-6), Tumor Necrosis Factor- (TNF-) and C-Reactive Protein (CRP) Do Not Predict Subsequent Hip Bone Loss in Men or Women: The Framingham Osteoporosis Study.
McLean Robert R., Zhang Xiaochun, Fontes Joao D. T., Meigs James B., Cupples L. Adrienne, Kiel Douglas P., Hannan Marian T.

B-Cell Profiling Using Multi-Color Flow Cytometry as Biomarker of Disease Progression in Primary Sjogren's Syndrome (pSS).
Roberts Mustimbo, Maguire Craig, Rosenberg Alex, Coca Andreea, Anolik Jennifer H., Sanz Iñaki

Before Beginning Anti-TNF, a Better Targeted Screening and a Twice Decrease Frequency of Latent Tuberculosis (TB) with IFN gamma Release Assays (IGRA) Compared with Tuberculin Skin Test. Results in 396 Patients from the ETAT Study.
Mariette Xavier, Baron Gabriel, Liote Frédéric, Goupille Philippe, Flipo René-Marc, Combe Bernard, Tubach Florence, Emilie Dominique, Salmon Dominique, Leman Marc, Carcelain Guislaine, Ravaud Philippe

Behcet's Disease and the Major Histocompatibility Complex: Looking beyond HLA-B51.
Ombrello Michael J., Kirino Yohei, Cosan Fulya, Gul Ahmet, Kastner Daniel L., Remmers Elaine F.

Belimumab, a BLyS-Specific Inhibitor, Improved Fatigue and SF-36 Physical and Mental Component Summary Scores in Patients with SLE: BLISS-76 and -52 Studies.
Strand V., Levy R. A., Cervera R., Petri M. A., Rudge H., Pineda L., Freimuth W., Zhong Z. J., Clarke A. E., for the BLISS-76 and -52 Study Group 

Belimumab, a BLyS-Specific Inhibitor, Reduced Corticosteroid Use in Patients with Active SLE: Results from the Phase 3 BLISS-52 and -76 Studies.
van Vollenhoven R. F., Gallacher A., Navarra S., Ginzler E. M., Dooley M. A., Cervera R., Li E. K., Levy R. A., Guzman R., Zhong Z. J., Cooper S., Pineda L., Hough D., Wallace D. J., for the BLISS-52 and -76 Study Groups 

Belimumab, a BLyS-Specific Inhibitor, Reduced Disease Activity across Multiple Organ Domains: Combined Efficacy Results from the Phase 3 BLISS-52 and -76 Studies.
Manzi S., Sanchez-Guerrero J., Merrill J. T., Furie R. A., Gladman D., Navarra S., Ginzler E. M., D'Cruz D., Doria A., Cooper S., Zhong Z. J., Hough D., Freimuth W., Petri M.

Belimumab, a BLyS-Specific Inhibitor, Reduced Disease Activity and Severe Flares in Seropositive SLE Patients: BLISS-76 Study Results through Wk 76.
Furie, R., Zamani, O., Wallace, D., Tegzova, D., Petri, M., Merrill, J.T., Chatham, W., Stohl, W., Schwarting, A., Cooper, S., Zhong, Z.J., Freimuth, W., Hough, D., van Vollenhoven, R.F.

Belimumab, a BLyS-Specific Inhibitor, Reduced Disease Activity, Flares, and Prednisone Use in Patients with Seropositive SLE: Combined Efficacy Results from the Phase 3 BLISS-52 and -76 Studies.
Petri M. A., Levy R. A., Merrill J. T., Navarra S., Cervera R., van Vollenhoven R. F., Manzi S., Gladman D., Gallacher A., Pineda L., Zhong Z. J., Hough D., Freimuth W., Furie R. A., for the BLISS-52 and -76 Study Groups 

Belimumab, a BLyS-Specific Inhibitor, Significantly Reduced Autoantibodies, Normalized Low Complement, and Reduced Selected B-Cell Populations in Patients with Seropositive Systemic Lupus Erythematosus (SLE): The Phase 3 BLISS Studies.
Stohl W., Hiepe F., Thomas M., Scheinberg M. A., Clarke A. E., Aranow C., Jimenez R., Wellborne F., Abud-Mendoza C., Hough D., Pineda L., Migone T. S., Freimuth W., Chatham W. W.

Bending the Cost Curve in Early RA: Sick Leave and Disability Pension before and after Initiation of Biologics or DMARD Combination Therapy.
Neovius Martin, Simard Julia F., Askling Johan, Group ARTIS Study

Beneficial Effects of Systemic IFN Are Mediated by IL-1Ra: Implications for Rheumatoid Arthritis.
Corr Mary, Boyle David L., Ronacher Lisa, Lew Brian R., van Baarsen Lisa G. M., Tak Paul P., Firestein Gary S.

Benefit of Intra-Articular Corticosteroid Injections by Oral and Maxillofacial Surgery Treating Temporomandibular Joint Arthritis in Children with Juvenile Idiopathic Arthritis.
Sharpe Tyler, Good Jennifer, Beukelman Timothy, Waite Peter, Cron Randy Q.

Best Scintigraphic Measures of Parotid Gland Dysfunction in Sjogren's Syndrome.
Keyes Anthony, Birnbaum Julius, Petronis John, Baer Alan N.

Better Results Are Achieved with Switching Directly to Biologics Than Switching Via DMARD Combinations in RA Patients Who Have Failed Methotrexate as Their Initial DMARD: Real Life Data from NOR-DMARD.
Lie Elisabeth, Uhlig Till, Mikkelsen Knut, Kalstad Synøve, Rodevand Erik, Kaufmann Cecilie, Kvien Tore K.

BILAG-Measured Improvement in Moderately and Severely Affected Body Systems in Patients with Systemic Lupus Erythematosus (SLE) by Epratuzumab: Results from EMBLEM, a Phase IIb Study.
Kalunian Kenneth C., Wallace Daniel J., Petri Michelle A., Houssiau Frederic A., Pike Marilyn C., Kilgallen Brian, Kelley Lexy, Gordon Caroline P.

Binding of Apoptotic Fetal Cardiocytes by Anti-Ro/La Antibodies Stimulates uPA/uPAR-Dependent Activation of TGFbeta and Potentiates Fibrosis.
Briassouli Paraskevi, Rifkin Daniel, Buyon Jill P., Clancy Robert M.

Binding Target for C-Reactive Protein Is Released from Secondary Necrotic Cells.
Janko Christina, Schorn Christine, Munoz Luis, Rauh Manfred, Lauber Kirsten, Schett Georg, Herrmann Martin

Biochemical Markers of Bone Balance (CTX-I/Osteocalcin) Improve with Tocilizumab Treatment in a Population of RA Patients with an Inadequate Response to Anti-TNF Therapy.
Karsdal Morten, Woodworth Thasia G., Kenwright Andy, Byrjalsesn Inger, Platt Adam, Schett Georg

Biologics and Risk of Lymphoma in Patients with Rheumatoid Arthritis: A Systematic Review and Meta-Analysis.
Burns Lindsay C., De Vera Mary, Bhole Vidula, Zhu Yanyan, Grayson Peter, Misra Devyani, Choi Hyon K.

Biologics Use in SLE in 7 CentersData from the International Registry for Biologics in SLE (IRBIS).
Van Vollenhoven Ronald, Jacobsen Søren, Wallace Daniel J., Hanly John G., Petri Michelle A., Isenberg David A., Clarke Ann E., Simard Julia F., Pineau Christian A., Bernatsky Sasha R., for the SLICC Group 

Biomarkers for Global and Renal Disease Activity in Juvenile Systemic Lupus Erythematosus (jSLE).
Mina Rina, Bennett Michael, Ahearn Joseph M., Pendl Joshua, Eaton Jamie, Wilson Nicole, Devarajan Prasad, Brunner Hermine

Biomarkers of Oxidative Stress, mTOR Activation, and Treg Depletion Correlate with Disease Activity in Patients with Systemic Lupus Erythematosus.
Lai Zhiwei, Bartos Adam, Tekarico Tiffany, Hanczko Robert, Miklossy Gabriella, Clair Brandon, Jimah John, Francis Lisa, Tily Hajra, Garcia Ricardo, Dawood Maha, Fernandez David R., Phillips Paul E., Coman Ioana, Perl Andras

Biomarkers Predictors of Good EULAR Response to B Cell Depletion Therapy (BCDT) in Seropositive Rheumatoid Arthritis Patients.
Ferraccioli Gianfranco, Tolusso Barbara, Pallavicini Francesca Bobbio, Gremese Elisa, Ravagnani Viviana, Benucci Maurizio, Podesta' Edoardo, Atzeni Fabiola, Peluso Giusy, Biasi G., Manfredi Mariangela, Puttini Piercarlo Sarzi, Lagana' Bruno, Montecucco Carlomaurizio

Bisphosphonate (BisP) Use May Be a Risk Factor for Osteonecrosis (ON) in Those Who Have Not Used Glucocorticoids (GCs): Data from the Health Improvement Network (THIN).
Vlad Steven C., Choi Hyon K., Peloquin Christine, Zhang Yuqing

Blinded Multi-Rater Evaluation of Diagnosis and Candidate Classification Criteria for Polymyalgia Rheumatica (PMR). ACREULAR Study Group for Development of Classification Criteria for PMR.
Matteson Eric L., Cimmino Marco A., Maradit-Kremers Hilal, Salvarani Carlo, Schirmer Michael, Schmidt Wolfgang A., Cid Maria C., Dejaco Christian, Duhaut Pierre, Schmidt Zsuzsa, Iagnocco Annamaria, Bachta Artur, Nannini Carlotta, Cantini Fabrizio, Martinez-Taboada Victor, Direskeneli Haner, Aydin Sibel Z., Luqmani Raashid, Pease Colin, Mazlumzadeh Mehrdad, Calamia Kenneth, Michet Clement J., Abril Andy, Gonter Neil, Crowson Cynthia S., Carter Rickey, Dasgupta Bhaskar

BLK Confers a Risk for Renal Involvement in Japanese Patients with Systemic Lupus Erythematosus.
Shimane Kenichi, Kochi Yuta, Yamada Ryo, Okada Yukinori, Suzuki Akari, Myouzen Keiko, Horita Tetsuya, Ishii Tomonori, Hirakata Michito, Amano Hirofumi, Kubo Michiaki, Nakamura Yusuke, Kamatani Naoyuki, Yamamoto Kazuhiko

BLK Is Expressed in Human Peripheral T Cells and Thymocytes and Regulates CD4 T Cell Numbers in Cord Blood.
Simpfendorfer Kim R., Olsson Lina, Manjarraz-Orduno Nataly, Khalili Houman, Lee Annette T., Gregersen Peter K.

Blockade of CD40L with a Monovalent Fab' PEG Monoclonal Antibody Inhibits Disease in the Murine Collagen-Induced Arthritis Model.
Vugler Alexander, Sutton Daniel, Marshall Diane, Shaw Stevan, Burkly Linda, Ferrant Janine, Garber Ellen, Shock Anthony

Blockade of TLR2 Prevents Spontaneous and Induced Cytokine Release from Rheumatoid Arthritis Ex Vivo Synovial Explant Cultures.
Ultaigh Sinead Nic An, Saber Tajvur, Dellacasagrande Jerome, Keogh Brian, McCormack William, Reilly Mary, Neill Luke O, McGuirk Peter, Fearon Ursula, Veale Douglas J.

Blockade of TNF or IL-1 Ameliorates Established C-Protein Induced Myositis of Mice.
Sugihara Takahiko, Okiyama Naoko, Watanabe Naoto, Miyasaka Nobuyuki, Kohsaka Hitoshi

BMS-582949 Is a Dual Action p38 Kinase Inhibitor Well Suited To Avoid Resistance Mechanisms That Increase p38 Activation in Cells.
Schieven Gary, Zhang Rosemary, Pitt Sidney, Shen Ding-Ren, Cao Jian, Sack John, Doweyko Arthur, Ross-MacDonald Petra

Body Composition Trends in Patients with Rheumatoid Arthritis: Associations with Disease Characteristics and Inflammatory Markers.
Kramer Henry R., Bathon Joan M., Giles Jon T.

Body Composition, Lower Extremity Strength, and Fatigue in SLE.
Katz Patricia, Julian Laura, Yazdany Jinoos, Wing Holly, Kaplan Sandi, Trupin Laura, Yelin Ed

Body Weight and Response to Biologics in RA and Spondyloarthritides. Obesity Reduces the Rate of Remission-Response. The GISEA Registry.
Ferraccioli Gianfranco, Trotta Francesco, Punzi Leonardo, Ferri Clodoveo, Sarzi-Puttini Piercarlo, Bambara Lisa Maria, Triolo Giovanni, Giacomelli Roberto, Gerli Roberto, Gorla Roberto, Marchesoni Angelo, Grassi Walter, Lapadula G.

Bone Density Following Long-Duration Spaceflight and Recovery.
Amin Shreyasee, Achenbach Sara, Atkinson Elizabeth, Melton L. Joseph, Khosla Sundeep, Sibonga Jean

Bone Density Measurement in Osteoarthritis Using Digital Radiographic Procedures.
Kinds M. B., Bartels L. W., Marijnissen A. C. A., Vincken K. L., de Jong H. W.A.M., Viergever M. A., Lafeber F. P. J. G.

Bone Events in Type 1 Gaucher Disease before and during Treatment.
Stirnemann Jerome, Heraoui Djazia, Vincent Corine, Fain Olivier, Fantin Bruno, Mentre France, Belmatoug Nadia

Bone Geometry Parameters among Black and White Women with SLE.
Alele Jimmy D., Kamen Diane L., Hunt Kelly J., Gilkeson Gary S., Ramsey-Goldman Rosalind

Bone Marrow Lesion (BML) Size in Osteoarthritic Knees Correlates with Extent of Cartilage Damage and Predicts Longitudinal Cartilage Loss.
Driban Jeffrey B., Lo Grace H., Lee Ji Yeon, Ward Robert J., Miller Eric, McAlindon Timothy E.

Bone Marrow Lesions (BMLs) Are Strongly Associated with Increased Bone Volume Fraction; Virtual Bone Biopsy Using MRI.
Tassinari Anna M., Lo Grace H., Driban Jeffrey, Price Lori Lyn, Schneider Erika, McAlindon Timothy E.

Bone Mineral Density and Body Composition in Systemic Sclerosis: A Case-Control Study.
Chiu Mok Chi, Yin Ho Ling, Hung To Chi, Man Ma Kwok

Bone Remodeling in Postmenopausal Women Who Discontinued Denosumab Treatment.
Wagman Rachel B., Brown Jaques, Dempster David W., Ding Beiying, Dent Ricardo, Martin Javier San, Grauer Andreas, Zanchetta Jose R.

Both Insulin Receptor and Nampt Activity Are Implicated in Visfatin/Nampt Induced PGE2 Synthesis in Articular Chondrocytes.
Gosset Marjolaine, Berenbaum Francis, Salvat Colette, Sautet Alain, Holzenberger Martin, Jacques Claire

Brain Activity in Patients with Chronic Knee Pain Due to Osteoarthritis: Dissociating Evoked from Spontaneous Pain.
Parks Elle L., Baliki Marwan N., Geha Paul Y., Schnitzer Thomas J., Apkarian Apkar V.

Breach of B Cell Tolerance in New Zealand Black Chromosome 1 Congenic Mice.
Chang Nan-Hua, Pau Evelyn, Loh Christina, Wither Joan E.

Bridging the Gap in Osteoporosis Care, Part I: Results of the SPOOF (Secondary Prevention of Osteoporotic Fracture) Project.
A. Langan Mary, J. Carey John, J. Coughlan Robert, Armstrong Catherine, O'Brien Assumpta, McNamara Sarah, Murphy Ella, Ballal Mohamed

Abstract Supplement

Meeting Menu